← Back to Search
Updates On Phase1b/2 Trial Of The Indoleamine 2,3-dioxygenase Pathway (IDO) Inhibitor Indoximod Plus Checkpoint Inhibitors For The Treatment Of Unresectable Stage 3 Or 4 Melanoma.
Published 2016 · Medicine
3075Background: IDO is an enzyme that catalyzes tryptophan to kynurenine. Tryptophan depletion enhances the function of the suppressive Treg and inhibits the effector T cells. Kynurenine metabolite...